[1] L.M. dos Santos, J.D. de Souza, H.A. Mbakwa, A.F.S. Nobre, R.C. Vieira, S.F. Ferrari, A.R. Rodrigues, E.A.Y. Ishikawa, J.F.
Guerreiro, M.S. de Sousa, High prevalence of sexual infection by human papillomavirus and Chlamydia trachomatis in sexuallyactive women from a large city in the Amazon region of Brazil, PLoS One. 17 (2022) e0270874.
[2] Castellsagué, X., Paavonen, J., Jaisamrarn, U. et al. Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial. BMC Infect Dis 14, 551 (2014)
[3] J. Tudela Cuenca, Sexual behaviour and the Human Papilloma Virus: New data, (2012).
A.N. della Fera, A. Warburton, T.L. Coursey, S. Khurana, A.A. McBride, Persistent human papillomavirus infection, Viruses. 13 (2021) 321.
[4] V. Cogliano, R. Baan, K. Straif, Y. Grosse, B. Secretan, F. el Ghissassi, Carcinogenicity of human papillomaviruses, Lancet
Oncol. 6 (2005) 204.
[5] Popescu SD, Boiangiu AG, Sima RM, Bilteanu L, Vladareanu S, Vladareanu R. Maternal HPV Infection and the Estimated Risks for Adverse Pregnancy Outcomes-A Systematic Review. Diagnostics (Basel). 2022;12(6):1471. Published 2022 Jun 15.
[6] Faber, M.T.; Duun-Henriksen, A.K.; Dehlendorff, C.; Tatla, M.K.; Munk, C.; Kjaer, S.K. Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy. Vaccine 2019, 37, 265–271
[7] Vojtek, I., Dieussaert, I. , Doherty, T. M., Franck, V., Hanssens, L., Miller, J., Bekkat-Berkani, R., Kandeil, W., Prado-Cohrs, D., & Vyse, A. (2018). Maternal immunization: where are we now and how to move forward?. Annals of medicine, 50(3), 193–208.
[8] Liu, P., Xu, L., Sun, Y Wang, Z. (2014). The prevalence and risk of human papillomavirus infection in pregnant
women. Epidemiology and Infection, 142(8), 1567-1578.
[9] Anwar, A., Igbenehi, C., Lindow, S. W., Noor, N., Musa, S., & Saha, A. (2016). Pregnancy outcome after electrosurgical cervical cone biopsy using Fischer cone biopsy excisor. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 29(3), 477–481.
[10] Khieu M, Butler SL. High Grade Squamous Intraepithelial Lesion. [Updated 2022 Jan 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430728/
[11] Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J. Low Genit Tract Disease 24(2): 102–131.
[12] AEPCC-Guía: PREVENCIÓN SECUNDARIA DEL CANCER DE CUELLO DEL ÚTERO, 2022. CONDUCTA CLÍNICA
ANTE RESULTADOS ANORMALES DE LAS PRUEBAS DE CRIBADO. Coordinador: Torné A. Secretaria: del Pino M.
Autores: Torné A; Andía, D; Bruni L; Centeno C; Coronado P; Cruz Quílez J; de la Fuente J; de Sanjosé S; Granados R; Ibáñez R; Lloveras B; Lubrano A Matías Guiu X; Medina N; Ordi J; Ramírez M; del Pino M
[13] Murta, E. F., de Souza, F. H., de Souza, M. A., & Adad, S. J. (2002). High-grade cervical squamous intraepithelial lesion during pregnancy. Tumori, 88(3), 246–250.
[14] Wright, T. C., Jr, Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., Solomon, D., & 2006 American Society for
Colposcopy and Cervical Pathology-sponsored Consensus Conference (2007). 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. American journal of obstetrics and gynecology, 197(4), 346–355.
[15] Gatta, Luke A. MD*; Kuller, Jeffrey A. MD†; Rhee, Eleanor H. J. MD‡. Pregnancy Outcomes Following Cervical Conization or Loop Electrosurgical Excision Procedures. Obstetrical & Gynecological Survey: August 2017 - Volume 72 - Issue 8 - p 494-499
[16] Ørtoft G, Henriksen T, Hansen E, Petersen L. After conisation of the cervix, the perinatal mortality as a result of preterm delivery increases in subsequent pregnancy. BJOG 2010;117: 258–67
[17] McIndoe, W. A., McLean, M. R., Jones, R. W., & Mullins, P. R. (1984). The invasive potential of carcinoma in situ of the
cervix. Obstetrics and gynecology, 64(4), 451–458.
[18] McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008). Natural history of
cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. The Lancet. Oncology, 9(5), 425–434.
[19] Dexeus D, Agüera J, Calderón MA, Centeno C, Coronado P, de la Fuente J, de Santiago J, Donaire MC, Fiol G, García C, González S, Gurrea M, Hernández JJ, Lago V, Lobo I, López AC, López JA, Lubrano A, Mancebo G, Palacios S, Quesada A, Riera M, Rodríguez I, Serrano L, Solé-Sedeno JM, Valenzuela O, Vanrell C, Mallafré A, Cortés J. Prevention and treatment of low-grade cervical lesions caused by HPV: evidence for a vaginal gel based on Coriolus versicolor. Toko - Gin Pract 2020; 79 (2)
[20] Serrano L, López AC, González S, Palacios S, Dexeus D, Centeno C, Coronado P, de la Fuente J, López Fernández J, Vanrell C and Cortés J. Efficacy of a Coriolus versicolor–Based Vaginal Gel in Women With Human Papillomavirus–Dependent Cervical
Lesions: The PALOMA Study. J Low Genit Tract Dis 2021;25: 130–136.
[21] González SP, Serrano L, Vezza T, Garrido Mesa J, Algieri F, Morón R, Rodríguez Cabezas ME, Gálvez J, Rodríguez Nogales A. Effect of a Coriolus versicolor-based vaginal gel on cervical epithelization and vaginal microbiota in HPV-positive women: EPICERVIX pilot study. Acad J Health Science. 2022;37(2): 139-45.
)
)